. Data Show India’s Homegrown COVID-19 Vaccine Works — 2 Months After It Was Approved « JO LEE MAGAZINE

NPR – It turns out a COVID-19 vaccine that stirred controversy in India may be effective after all. The Indian government approved the use of the COVAXIN vaccine, made by the Indian company Bharat Biotech, on Jan. 3 – while clinical trials were ongoing, and before efficacy data was out. Scientists, public health experts and opposition politicians expressed concern. Many called the move premature. Some accused India of acting out of nationalism. The Bharat Biotech formula has been billed as India’s first “indigenous” vaccine. Critics cautioned India to wait for data from phase 3 clinical trials. Now, that data is out.

More details at NPR 

Corbis via Getty Images


Comments are closed.